Eve Review: Price, Pros & Cons
Eve is a women's-health-focused GLP-1 telehealth brand offering both compounded and brand-name (Ozempic, Wegovy, Mounjaro) options per its navigation menu.
In this review
Prices at a glance
- Semaglutide
- Not disclosed
- Tirzepatide
- Not disclosed
- Coverage
- Coverage not published
- Brand-name
- Yes
Who Eve may suit
Women who want a women's-health brand offering compounded or brand-name GLP-1s, and who will start intake to see a real price.
Where the value is
- Genuinely women's-health-focused positioning, distinct from the mostly gender-neutral field
- Nav confirms both compounded and FDA-approved brand-name options (Ozempic, Wegovy, Mounjaro) on one platform
- '$0 unless approved by a licensed physician' means no charge before a prescriber signs off
The tradeoffs
- No price is published on the site, and several of its pages (pricing, FAQ, legal) are missing, so get the terms in writing before you pay
- The only pricing clue is a '$99' string embedded in an intake-link promo parameter; its meaning is never explained in visible page text
- No states-served list, pharmacy partner, LegitScript status, or named medical director published anywhere reached
- Getting any real price requires starting a full-identity signup flow
What Eve tells you about price
Eve doesn't publish a price for any of its GLP-1 treatments. Its site promises "100% transparent, risk-free pricing" and says you pay nothing unless a licensed physician approves you, but no figure is shown before you start the online visit. Plans are sold as a subscription that you can cancel at any time, shipping is free, and you don't need insurance.
That makes Eve hard to compare before you commit time to an intake. When you get to checkout, ask for the monthly price at your starting dose, what it becomes as the dose rises, how often you're billed, and whether a longer commitment is required for the advertised rate.
Considering Eve?
Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.
What Eve sells
Eve's product list includes a compounded GLP-1 therapy alongside three brand-name drugs: Mounjaro, Ozempic and Wegovy. It notes that physicians may prescribe compounded medications when needed, and that the FDA doesn't review or approve compounded drugs. Its site navigation also points to compounded tirzepatide. Eve also offers longevity and hair health treatments.
Eve doesn't say whether the brand-name drugs are billed through insurance or at cash price, or whether the medication cost is included in the subscription. Ask before you choose a brand-name drug, since those usually cost far more than a compounded one.
How care works
Eve Health, Inc. runs the platform. It doesn't provide medical care itself. Instead, it connects you with independent licensed providers through affiliated professional entities. The steps are: create an account, schedule a telehealth appointment, consult with a provider about your goals and history, and, if prescribed, have the medication shipped to your door. Eve says you'll be matched with a board-certified obesity medicine physician.
After that, you can message your assigned provider through a secure patient portal, and follow-up check-ins are scheduled to track progress and adjust your dose. If you travel or move, your provider must be licensed in the state where you are at the time of a visit, and Eve says its team can connect you with one there.
Gaps to close before you pay
Eve's terms say some services are only available in certain states, but it doesn't list them. It also doesn't name its pharmacy or its medical director. The homepage promises a satisfaction guarantee, "or your money back," without stating the conditions.
- Confirm your state is covered before you book the appointment.
- Get the guarantee's conditions in writing.
- Ask which pharmacy fills the prescription.
- Ask how to cancel and how far before a renewal you need to do it.
The Index scorecard
Eve scored on our six Cost-Efficiency Index factors. See the methodology.
The bottom line
Eve is a women's-health-focused GLP-1 telehealth brand offering both compounded and brand-name (Ozempic, Wegovy, Mounjaro) options per its navigation menu.
Compare the total cost of other GLP-1 programs and alternatives to Eve before deciding. A clinician should help you choose the right treatment.
Other programs to compare with Eve
These are partners: we may earn a commission if you sign up, at no cost to you.
ShedRx (Shed)Partner
Semaglutide modeled $199/mo · Tirzepatide modeled $299/mo
Shed sells its GLP-1s as an injection, drops, lozenges or a daily pill, with brand-name Zepbound too; month to month, semaglutide is $199 and tirzepatide $299.
Strut HealthPartner
Semaglutide modeled $99/mo · Tirzepatide modeled $149/mo
Strut sells compounded semaglutide from $99 a month as a lozenge or $129 as a weekly injection, and tirzepatide from $149, all on auto-refill.
bmiMDPartner
Semaglutide modeled $159/mo · Tirzepatide modeled $249/mo
bmiMD charges $159 a month for compounded semaglutide and $249 for tirzepatide month to month, the same at every dose, with lower prices on three-, six- and twelve-month plans.
Compare with other providers
The providers whose Cost-Efficiency Index scores sit closest to Eve's. See the alternatives to Eve.
- Rugiet— Rugiet sells ED, testosterone and men's health treatments plus Weigh In, an oral bupropion, naltrexone and metformin plan; it doesn't sell GLP-1 medication.43/100
- Grüns— Grüns sells greens supplement gummies by subscription from about $1.78 a day; it isn't a prescriber and doesn't sell GLP-1 medication.43/100
- Future— Future is remote one-on-one personal training at $50 for the first month, then $199 a month; it isn't a prescriber and doesn't sell GLP-1 medication.43/100
- HumeCare+— HumeCare is a telehealth weight-loss platform genuinely prescribing semaglutide or tirzepatide (chosen by a named physician) with muscle-preserving B-vitamin supplementation and a proprietary body-composition tracker.42/100
- Glam Health— Low advertised prices on both molecules plus NAD+, but few trust signals — no LegitScript, no named clinicians or pharmacy, and no state list.42/100
- TideMedix— TideMedix advertises a shared $99 first-month GLP-1 program floor. It offers semaglutide and tirzepatide assessment paths but does not publish separate standing monthly prices.42/100
Pricing, states and verification reflect Eve's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Eve's site. Not medical advice; see our disclosure.